RECENT NEWS
INTEGRA Biosciences competition winner looks to transform cell culture
INTEGRA Biosciences is delighted to announce that Alt Biotech – an innovative French start-up making waves in the cell culture space – has been chosen as a winner of the 'INTEGRA supports start-ups’ competition.
FormaPath unveils novel tissue biopsy grossing platform
FormaPath has unveiled nToto, a new automated tissue visualisation system (ATVS) developed in collaboration with Mayo Clinic's Advanced Diagnostics Laboratory. The new system was launched in conjunction with a poster presentation at the United States and Canada Association of Pathologists Annual (USCAP) meeting.
London pathologists voting on strike action over hub move
Hundreds of pathologists in London are being balloted over strike action over a planned restructure by employer Synnovis, which the Unite union claims is unwanted and damaging.
FDA approves Roche’s molecular blood test for malaria
Roche has announced the US Food and Drug Administration (FDA) approval of the cobas Malaria test for use on the cobas 6800/8800 Systems. This approved test can aid healthcare professionals in reducing potential risks of patient infection from transfused blood products. The cobas Malaria test provides a highly sensitive and specific solution to help ensure that infected blood units are removed from the blood supply.
Sarstedt hosts sample transport symposium
Laboratory supplier Sarstedt hosted a two-day educational Transport Symposium at its Leicester base during March. An audience of NHS managers and biomedical scientists were present for a variety of presentations as well as a hands-on preview of the Tempus600 transport system.
Bio-Rad launches validated antibodies for cell enumeration
Bio-Rad Laboratories has launched new validated antibodies for rare cell and circulating tumour cell (CTC) enumeration. Validated for use with Bio-Rad’s Celselect Slides Enumeration Stain Kits, the antibodies are specific to CTC surface markers to enable the sensitive and specific identification of target cell populations, enhancing the study of tumour heterogeneity and disease progression at various stages.
Helen Dent appointed as BIVDA Chief Executive
The British In Vitro Diagnostic Association (BIVDA) has confirmed the appointment of Helen Dent as Chief Executive, following a successful period as Interim Chief Executive. Helen will lead BIVDA in championing the medical diagnostics industry to politicians, policymakers, media and relevant stakeholders and in supporting members to improve patient outcomes.
Presymptom Health developing AI-driven sepsis and infection tests for the NHS
UK start-up Presymptom Health has raised £1.5m to help accelerate time to market of its AI-driven sepsis and infection tests - with the company aiming to roll-out its technology to the NHS from mid-2025.
NHS expands lung cancer blood test trial
A blood test which could help thousands of people receive earlier, more targeted, lung cancer treatments is being trialled by the NHS. The circulating tumour DNA (ctDNA) test, which will be offered to 10,000 patients by next March, can identify genetic variants in a tumour through a simple blood sample.
NPIC re-running digital pathology webinars
The National Pathology Imaging Co-Operative (NPIC) is re-running its 2023 educational webinar series on digital pathology, ‘Innovation into Practice’.
Clinical biomarker tools and technologies for dementia receive funding
Innovate UK is pleased to announce the winners of a funding competition to develop new clinical tools for dementia and neurodegeneration. Ten new projects will receive funding for identification, development and commercialisation of biomarker tools and technologies.
CytoFLEX nano flow cytometer pushes boundaries of EV detection
Beckman Coulter Life Sciences has launched its new CytoFLEX nano Flow Cytometer – the first purpose-built nanoscale flow cytometer for research use only that enables detection to at least 40 nm, enabling 30-50% more data creation.
Owkin and University Hospitals Birmingham collaborate on AI diagnostics for colorectal cancer
Owkin and University Hospitals Birmingham NHS Foundation Trust (UHB) have announced a new five-year research partnership to use artificial intelligence (AI) to accelerate the screening and diagnosis of a range of diseases, starting with colorectal cancer.
QDx Pathology Services adopts Proscia’s software
QDx Pathology Services, an independent anatomical, molecular and clinical pathology laboratory serving medical professionals and facilities throughout the United States, is working with Proscia, a leading provider of digital and computational pathology solutions, to innovate its practice. The laboratory has deployed Proscia’s software to enable its pathologists to work faster and more confidently.
New research to develop vaccines against deadly henipaviruses
A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against Henipavirus – a genus of viruses including Nipah virus. The research has been funded by the Medical Research Council.
New mpox vaccine being tested in the UK
A new mpox vaccine is being tested in the UK, as the virus continues to spread in many parts of the world. The mPower trial is testing the effectiveness of an investigational mRNA vaccine for mpox. The study is delivered by NIHR Clinical Research Network (CRN) and sponsored by Moderna.
Potential novel biomarkers of coronary heart disease discovered
Coronary heart disease (CHD) is a major global health problem, especially among people with type 2 diabetes. Researchers at the German Center for Diabetes Research (DZD), Helmholtz Munich, and Ludwig-Maximilians-University Munich (LMU) have identified novel protein biomarkers that are associated with the development of CHD in people with and without diabetes.
Global consortium launches studies to discover transmission-blocking coronavirus vaccines
An international consortium of researchers specialising in human challenge studies is embarking on a US$57 million project to develop advanced, virus-blocking coronavirus vaccines that could stop SARS-CoV-2 and other coronaviruses from infecting people.
Lunit SCOPE AI enhances pathologist concordance and accuracy in HER2, ER, and PR assessment
A new study shows Lunit’s AI-powered cancer diagnostic solutions SCOPE HER2 and SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care.
OptraSCAN launches new image management and storage solution
End-to-end digital pathology solution provider OptraSCAN has announced the introduction of a combined image management and image storage solution, to enable and simplify the digital transformation of pathology laboratories. The OptraSCAN IMAGEPath image management system is an open platform that can easily integrate with scanners from multiple manufacturers and over 20 different image formats, in addition to being compatible with external third-party AI applications for pathology.
Upcoming Events
Pathology Horizons 2024
MacDonald Bath Spa Hotel, Bath
18-20 April, 2024
Diagnostics North East Conference 2024
The Catalyst, Newcastle upon Tyne
19 April, 2024
ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases
Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024
British Society for Microbial Technology Annual Microbiology Conference
UK Health Security Agency, Colindale, London
2 May 2024
EQA Reports: Interpreting Key Information & Troubleshooting Tips
ONLINE - Zoom
Thursday 16th May 2024
Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy
Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store